Tag: Prescription Drugs
Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure
Lower risk for cardiovascular death or hospital admission seen in HF with reduced ejection fraction
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Benzodiazepines, Codispensed Opioids Common in Hemodialysis
Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Remdesivir Beats Placebo for Time to COVID-19 Recovery
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Antiobesity Meds May Curb Weight Regain After RYGB
Statistical models suggest phentermine, topiramate, combination can slow, prevent weight regain
Melanoma Risk From Biologic Therapy Remains Uncertain
Systematic literature review and meta-analysis reveal link to increased risk cannot be ruled out
Sex Differences ID’d in Prescription of Cardiovascular Meds
Women are less likely to be prescribed aspirin, statins, antihypertensive medications, including ACEIs
Hydroxychloroquine Does Not Improve COVID-19 Pneumonia Outcomes
Second study shows no benefit versus standard of care in probability of negative conversion by 28 days
